Understanding and Priming the Pre-Visit Patient

Date/Time: Available on demand
Click here to view on demand

The point at which a patient plans and schedules a visit to their doctor represents a significant window of opportunity for promoting treatment options and maximizing the growth of specific brands. Experts in patient engagement and marketing from the pharmaceutical, agency and media fields discuss pharma's role in priming the pre-visit patient for a more beneficial dialogue with their physician.

Featured speakers: 
Mike Boken, Senior Director of Marketing, Vyvanse, Shire
Robert Palmer, Managing Partner, S&H Digital, Sudler & Hennessey Company
Jan R. Rutherford, Jr., Senior Vice President, Sponsorship and Advertising, HealthGrades


Sponsored by HealthGrades
You must be a registered member of MMM to post a comment.

Pharma continues to struggle with its image. Exhibit A is the public debate around the price of, and access to, new and innovative meds. As countless transformative technologies hit market, has industry done enough to anchor its permission to innovate? To provide a closer look at trends affecting trust over the past year, MM&M presents this e-book, "The 2015 Edelman Trust Barometer." Click here.

Email Newsletters